Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission

Nicholas J. Short; Walid Macaron; Tapan Kadia; Courtney Dinardo; Ghayas C. Issa; Naval Daver; Sa Wang; Jeff Jorgensen; Daniel Nguyen; Aram Bidikian; Keyur P. Patel; Sanam Loghavi; Marina Konopleva; Musa Yilmaz; Elias Jabbour; Abhishek Maiti; Hussein A. Abbas; Elizabeth Shpall; Uday Popat; Gheath Al-Atrash; Sherry Pierce; Hagop M. Kantarjian; Farhad Ravandi

doi:10.1002/ajh.26698

Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission

Nicholas J. Short, Walid Macaron, Tapan Kadia, Courtney Dinardo, Ghayas C. Issa, Naval Daver, Sa Wang, Jeff Jorgensen, Daniel Nguyen, Aram Bidikian, Keyur P. Patel, Sanam Loghavi, Marina Konopleva, Musa Yilmaz, Elias Jabbour, Abhishek Maiti, Hussein A. Abbas, Elizabeth Shpall, Uday Popat, Gheath Al-AtrashSherry Pierce, Hagop M. Kantarjian, Farhad Ravandi

Research output: Contribution to journal › Letter › peer-review

9 Scopus citations

Original language	English (US)
Pages (from-to)	E408-E411
Journal	American journal of hematology
Volume	97
Issue number	11
DOIs	https://doi.org/10.1002/ajh.26698
State	Published - Nov 2022

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.26698

Cite this

Short, N. J., Macaron, W., Kadia, T., Dinardo, C., Issa, G. C., Daver, N., Wang, S., Jorgensen, J., Nguyen, D., Bidikian, A., Patel, K. P., Loghavi, S., Konopleva, M., Yilmaz, M., Jabbour, E., Maiti, A., Abbas, H. A., Shpall, E., Popat, U., ... Ravandi, F. (2022). Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission. American journal of hematology, 97(11), E408-E411. https://doi.org/10.1002/ajh.26698

Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission. / Short, Nicholas J.; Macaron, Walid; Kadia, Tapan et al.
In: American journal of hematology, Vol. 97, No. 11, 11.2022, p. E408-E411.

Research output: Contribution to journal › Letter › peer-review

Short, NJ, Macaron, W, Kadia, T , Dinardo, C , Issa, GC , Daver, N , Wang, S , Jorgensen, J, Nguyen, D, Bidikian, A, Patel, KP , Loghavi, S, Konopleva, M, Yilmaz, M , Jabbour, E , Maiti, A , Abbas, HA , Shpall, E , Popat, U , Al-Atrash, G, Pierce, S, Kantarjian, HM & Ravandi, F 2022, 'Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission', American journal of hematology, vol. 97, no. 11, pp. E408-E411. https://doi.org/10.1002/ajh.26698

@article{6b568eefbecc4a5d88e093c742db08d2,

title = "Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission",

author = "Short, {Nicholas J.} and Walid Macaron and Tapan Kadia and Courtney Dinardo and Issa, {Ghayas C.} and Naval Daver and Sa Wang and Jeff Jorgensen and Daniel Nguyen and Aram Bidikian and Patel, {Keyur P.} and Sanam Loghavi and Marina Konopleva and Musa Yilmaz and Elias Jabbour and Abhishek Maiti and Abbas, {Hussein A.} and Elizabeth Shpall and Uday Popat and Gheath Al-Atrash and Sherry Pierce and Kantarjian, {Hagop M.} and Farhad Ravandi",

note = "Funding Information: This study is supported by an MD Anderson Cancer Center Support Grant (CA016672). Nicholas J. Short is supported by the K12 Paul Calabresi Clinical Oncology Scholar Award and the American Society of Hematology Junior Faculty Scholar Award in Clinical Research. ",

year = "2022",

month = nov,

doi = "10.1002/ajh.26698",

language = "English (US)",

volume = "97",

pages = "E408--E411",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "11",

}

TY - JOUR

T1 - Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission

AU - Short, Nicholas J.

AU - Macaron, Walid

AU - Kadia, Tapan

AU - Dinardo, Courtney

AU - Issa, Ghayas C.

AU - Daver, Naval

AU - Wang, Sa

AU - Jorgensen, Jeff

AU - Nguyen, Daniel

AU - Bidikian, Aram

AU - Patel, Keyur P.

AU - Loghavi, Sanam

AU - Konopleva, Marina

AU - Yilmaz, Musa

AU - Jabbour, Elias

AU - Maiti, Abhishek

AU - Abbas, Hussein A.

AU - Shpall, Elizabeth

AU - Popat, Uday

AU - Al-Atrash, Gheath

AU - Pierce, Sherry

AU - Kantarjian, Hagop M.

AU - Ravandi, Farhad

N1 - Funding Information: This study is supported by an MD Anderson Cancer Center Support Grant (CA016672). Nicholas J. Short is supported by the K12 Paul Calabresi Clinical Oncology Scholar Award and the American Society of Hematology Junior Faculty Scholar Award in Clinical Research.

PY - 2022/11

Y1 - 2022/11

UR - http://www.scopus.com/inward/record.url?scp=85137525560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85137525560&partnerID=8YFLogxK

U2 - 10.1002/ajh.26698

DO - 10.1002/ajh.26698

M3 - Letter

C2 - 36054774

AN - SCOPUS:85137525560

SN - 0361-8609

VL - 97

SP - E408-E411

JO - American journal of hematology

JF - American journal of hematology

IS - 11

ER -

Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this